Skip to contentC
Cannabis Suisse Corp.
C
CSUICannabis Suisse Corp. Q3 2026 · 10-Q
Revenue$0.00$0.00−100.0% vs Q3 2025 Net Income$26.91K$26.91K−8.8% vs Q3 2025 EPS Diluted$0.00$0.00— vs Q3 2025 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cannabis Suisse Corp. · CIK 1680132 · Engraved from SEC EDGAR
Operating Cash Flowderived-$17,500N/M ended Feb 28, 2026 · filed Apr 20, 2026 · 51 d after period end